lactic acid has been researched along with Staphylococcal Infections in 60 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
Staphylococcal Infections: Infections with bacteria of the genus STAPHYLOCOCCUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The purpose of this study was to investigate the curative effect of bone-like hydroxyapatite/poly amino acid (BHA/PAA) as a carrier for poly(lactic-co-glycolic acid)-coated rifapentine microsphere (RPM) in the treatment of rabbit chronic osteomyelitis induced by Staphylococcus aureus." | 7.81 | Treatment of Staphylococcus aureus-induced chronic osteomyelitis with bone-like hydroxyapatite/poly amino acid loaded with rifapentine microspheres. ( Cao, ZD; Jiang, DM; Li, YJ; Wang, X; Wang, ZL; Wu, J; Yan, L; Yi, YF, 2015) |
| "To prepare the vancomycin hydrochloride (VA)-loaded poly lactic acid-glycolic acid (PLGA) copolymer microsphere by the multiple emulsion method and evaluate its therapeutic effects on infective discitis." | 7.77 | Intra-discal vancomycin-loaded PLGA microsphere injection for MRSA discitis: an experimental study. ( Liu, F; Liu, J; Ni, B; Wang, F; Zhu, YZ; Zhu, Z, 2011) |
| "A novel biodegradable system of D-,L-dilactide delivering pefloxacin was implanted in 104 rabbits with experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus (MRSA), 26 serving as controls." | 7.70 | Treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with a biodegradable system of lactic acid polymer releasing pefloxacin. ( Andreopoulos, A; Dounis, E; Galanakis, N; Giamarellos-Bourboulis, EJ; Giamarellou, H; Kanellakopoulou, K; Karagianakos, P; Papakostas, K; Rifiotis, C, 2000) |
| "The purpose of this study was to investigate the curative effect of bone-like hydroxyapatite/poly amino acid (BHA/PAA) as a carrier for poly(lactic-co-glycolic acid)-coated rifapentine microsphere (RPM) in the treatment of rabbit chronic osteomyelitis induced by Staphylococcus aureus." | 3.81 | Treatment of Staphylococcus aureus-induced chronic osteomyelitis with bone-like hydroxyapatite/poly amino acid loaded with rifapentine microspheres. ( Cao, ZD; Jiang, DM; Li, YJ; Wang, X; Wang, ZL; Wu, J; Yan, L; Yi, YF, 2015) |
| "To prepare the vancomycin hydrochloride (VA)-loaded poly lactic acid-glycolic acid (PLGA) copolymer microsphere by the multiple emulsion method and evaluate its therapeutic effects on infective discitis." | 3.77 | Intra-discal vancomycin-loaded PLGA microsphere injection for MRSA discitis: an experimental study. ( Liu, F; Liu, J; Ni, B; Wang, F; Zhu, YZ; Zhu, Z, 2011) |
| " Systemic antibiotics often do not reach "dead-space" hematomas where bacteria harbor after surgery, whereas local, controlled release gentamicin prophylaxis through PLGA microspheres showed favorable pharmacokinetics data to achieve local bactericidal concentrations for up to 7 days after surgery." | 3.75 | Reduction of postoperative spinal implant infection using gentamicin microspheres. ( Becker, E; Gelb, D; Ludwig, SC; Poelstra, KA; Stall, AC, 2009) |
| "A novel biodegradable system of D-,L-dilactide delivering pefloxacin was implanted in 104 rabbits with experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus (MRSA), 26 serving as controls." | 3.70 | Treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with a biodegradable system of lactic acid polymer releasing pefloxacin. ( Andreopoulos, A; Dounis, E; Galanakis, N; Giamarellos-Bourboulis, EJ; Giamarellou, H; Kanellakopoulou, K; Karagianakos, P; Papakostas, K; Rifiotis, C, 2000) |
| "Healing of equine wounds, particularly in the limbs, is difficult due to hydrostatic factors and exposure to environmental contaminants, which can lead to heavy bio-burden/biofilm formation and sometimes to infection." | 1.43 | Fighting Off Wound Pathogens in Horses with Honeybee Lactic Acid Bacteria. ( Butler, É; Lindholm, C; Michanek, P; Nilson, B; Olofsson, TC; Vásquez, A, 2016) |
| "Titanium implants have been widely used for many medical applications, but bacterial infection after implant surgery remains one of the most common and intractable complications." | 1.42 | Antibacterial activity and biological performance of a novel antibacterial coating containing a halogenated furanone compound loaded poly(L-lactic acid) nanoparticles on microarc-oxidized titanium. ( Cheng, Y; Gao, B; Liu, X; Ren, H; Sun, W; Wu, J; Zhao, X, 2015) |
| "652 mg PLGA/ml) by MTT assay and the study of cellular up-take assessed on human fibroblasts confirmed the feasibility to formulate a dosage form useful for vaccination against S." | 1.39 | Sub-unit vaccine against S. aureus-mediated infections: set-up of nano-sized polymeric adjuvant. ( Caliceti, P; Colonna, C; Conti, B; Dorati, R; Genta, I, 2013) |
| " Hence, these microspheres may be potentially useful in the clinical setting with the need for further investigation for optimal dosing of TCP–PLGA microspheres." | 1.36 | Biodegradable microspherical implants containing teicoplanin for the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis. ( Ahiskali, R; Cevher, E; Mülazimoğlu, L; Orhan, Z; Sensoy, D; Yildiz, A, 2010) |
| "Osteomyelitis was established in 40 New Zealand White rabbits using Staphylococcus aureus." | 1.32 | Effective treatment of osteomyelitis with biodegradable microspheres in a rabbit model. ( Ambrose, CG; Clyburn, TA; Gogola, GR; Gulati, P; Joseph, J; Louden, K; Mikos, AG; Wright, J, 2004) |
| "Osteomyelitis is generally treated by the systemic administration of antibiotics and continuous irrigation after curettage of the lesion, and bone graft is performed secondarily to treat any bone defect." | 1.30 | Apatite cement containing antibiotics: efficacy in treating experimental osteomyelitis. ( Ishii, Y; Sasaki, S, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (11.67) | 18.7374 |
| 1990's | 8 (13.33) | 18.2507 |
| 2000's | 9 (15.00) | 29.6817 |
| 2010's | 29 (48.33) | 24.3611 |
| 2020's | 7 (11.67) | 2.80 |
| Authors | Studies |
|---|---|
| Schwenker, JA | 1 |
| Schotte, U | 1 |
| Hölzel, CS | 1 |
| Karacan, I | 1 |
| Ben-Nissan, B | 1 |
| Santos, J | 1 |
| Yiu, S | 1 |
| Bradbury, P | 1 |
| Valenzuela, SM | 1 |
| Chou, J | 1 |
| Baheerathan, A | 1 |
| Pitceathly, RD | 1 |
| Curtis, C | 1 |
| Davies, NW | 1 |
| Heim, CE | 1 |
| Bosch, ME | 1 |
| Yamada, KJ | 1 |
| Aldrich, AL | 1 |
| Chaudhari, SS | 1 |
| Klinkebiel, D | 1 |
| Gries, CM | 1 |
| Alqarzaee, AA | 1 |
| Li, Y | 1 |
| Thomas, VC | 1 |
| Seto, E | 1 |
| Karpf, AR | 1 |
| Kielian, T | 1 |
| Da Costa, D | 1 |
| Exbrayat-Héritier, C | 1 |
| Rambaud, B | 1 |
| Megy, S | 1 |
| Terreux, R | 1 |
| Verrier, B | 1 |
| Primard, C | 1 |
| Parente, CS | 1 |
| Sandland-Taylor, LE | 1 |
| Akhtar, W | 1 |
| Wang, J | 1 |
| Applefeld, WN | 1 |
| Sun, J | 1 |
| Solomon, SB | 1 |
| Feng, J | 1 |
| Couse, ZG | 1 |
| Risoleo, TF | 1 |
| Danner, RL | 1 |
| Tejero, J | 1 |
| Lertora, J | 1 |
| Alipour, E | 1 |
| Basu, S | 1 |
| Sachdev, V | 1 |
| Kim-Shapiro, DB | 1 |
| Gladwin, MT | 1 |
| Klein, HG | 1 |
| Natanson, C | 1 |
| Reinbold, J | 1 |
| Hierlemann, T | 1 |
| Urich, L | 1 |
| Uhde, AK | 1 |
| Müller, I | 1 |
| Weindl, T | 1 |
| Vogel, U | 1 |
| Schlensak, C | 1 |
| Wendel, HP | 1 |
| Krajewski, S | 1 |
| Bino, E | 1 |
| Lauková, A | 2 |
| Ščerbová, J | 2 |
| Kubašová, I | 1 |
| Kandričáková, A | 2 |
| Strompfová, V | 1 |
| Miltko, R | 1 |
| Belzecki, G | 1 |
| Colonna, C | 2 |
| Dorati, R | 2 |
| Conti, B | 2 |
| Caliceti, P | 2 |
| Genta, I | 2 |
| Esnault, P | 1 |
| Cotte, J | 1 |
| Cungi, PJ | 1 |
| Romanat, PE | 1 |
| Boret, H | 1 |
| McLaren, JS | 1 |
| White, LJ | 1 |
| Cox, HC | 1 |
| Ashraf, W | 1 |
| Rahman, CV | 1 |
| Blunn, GW | 1 |
| Goodship, AE | 1 |
| Quirk, RA | 1 |
| Shakesheff, KM | 1 |
| Bayston, R | 1 |
| Scammell, BE | 1 |
| Kankilic, B | 2 |
| Bilgic, E | 1 |
| Korkusuz, P | 1 |
| Korkusuz, F | 2 |
| Neut, D | 1 |
| Dijkstra, RJ | 1 |
| Thompson, JI | 1 |
| Kavanagh, C | 1 |
| van der Mei, HC | 1 |
| Busscher, HJ | 1 |
| Cheng, Y | 1 |
| Zhao, X | 1 |
| Liu, X | 1 |
| Sun, W | 1 |
| Ren, H | 1 |
| Gao, B | 1 |
| Wu, J | 3 |
| de Bree, LC | 1 |
| van Rijen, MM | 1 |
| Coertjens, HP | 1 |
| van Wijngaarden, P | 1 |
| Vitko, NP | 2 |
| Spahich, NA | 1 |
| Richardson, AR | 2 |
| Yan, L | 1 |
| Jiang, DM | 1 |
| Cao, ZD | 1 |
| Wang, X | 1 |
| Wang, ZL | 1 |
| Li, YJ | 1 |
| Yi, YF | 1 |
| de Breij, A | 1 |
| Riool, M | 1 |
| Kwakman, PH | 1 |
| de Boer, L | 1 |
| Cordfunke, RA | 1 |
| Drijfhout, JW | 1 |
| Cohen, O | 2 |
| Emanuel, N | 2 |
| Zaat, SA | 1 |
| Nibbering, PH | 1 |
| Moriarty, TF | 1 |
| Lee, MY | 1 |
| Bourgeois, S | 1 |
| Almouazen, E | 1 |
| Pelletier, J | 1 |
| Renaud, F | 1 |
| Fessi, H | 1 |
| Kodjikian, L | 1 |
| Olofsson, TC | 1 |
| Butler, É | 1 |
| Lindholm, C | 1 |
| Nilson, B | 1 |
| Michanek, P | 1 |
| Vásquez, A | 1 |
| Salmaso, S | 1 |
| Speziale, P | 1 |
| Pietrocola, G | 1 |
| Chiesa, E | 1 |
| Modena, T | 1 |
| Stall, AC | 1 |
| Becker, E | 1 |
| Ludwig, SC | 1 |
| Gelb, D | 1 |
| Poelstra, KA | 1 |
| Orhan, Z | 1 |
| Cevher, E | 1 |
| Yildiz, A | 1 |
| Ahiskali, R | 1 |
| Sensoy, D | 1 |
| Mülazimoğlu, L | 1 |
| Cardillo, JA | 1 |
| Paganelli, F | 1 |
| Melo, LA | 1 |
| Silva, AA | 1 |
| Pizzolitto, AC | 1 |
| Oliveira, AG | 1 |
| Wang, F | 1 |
| Ni, B | 1 |
| Zhu, Z | 1 |
| Liu, F | 1 |
| Zhu, YZ | 1 |
| Liu, J | 1 |
| de Sousa, FO | 1 |
| Blanco-Méndez, J | 1 |
| Pérez-Estévez, A | 1 |
| Seoane-Prado, R | 1 |
| Luzardo-Álvarez, A | 1 |
| Bayramli, E | 1 |
| Kilic, E | 1 |
| Dağdeviren, S | 1 |
| Said, SS | 1 |
| El-Halfawy, OM | 1 |
| El-Gowelli, HM | 1 |
| Aloufy, AK | 1 |
| Boraei, NA | 1 |
| El-Khordagui, LK | 1 |
| Lee, JH | 2 |
| Gu, Y | 1 |
| Wang, H | 1 |
| Lee, WY | 1 |
| Moon, SK | 1 |
| Kim, KM | 1 |
| Kim, KN | 1 |
| Chen, L | 1 |
| Li, S | 1 |
| Wang, Z | 1 |
| Chang, R | 1 |
| Su, J | 1 |
| Han, B | 1 |
| Rosenfeld, Y | 1 |
| Applbaum, YH | 1 |
| Segal, D | 1 |
| Barenholz, Y | 1 |
| Jamal, T | 1 |
| Rahman, MA | 1 |
| Mirza, MA | 1 |
| Panda, AK | 1 |
| Talegaonkar, S | 1 |
| Iqbal, Z | 1 |
| Cai, W | 1 |
| Xi, C | 1 |
| Meyerhoff, ME | 1 |
| Fuller, JR | 1 |
| Perkowski, EF | 1 |
| Scott, E | 1 |
| Khatri, D | 1 |
| Spontak, JS | 1 |
| Thurlow, LR | 1 |
| van Dijk, M | 1 |
| Smit, TH | 1 |
| Burger, EH | 1 |
| Wuisman, PI | 1 |
| Baumert, N | 1 |
| von Eiff, C | 1 |
| Schaaff, F | 1 |
| Peters, G | 1 |
| Proctor, RA | 1 |
| Sahl, HG | 1 |
| GERSHANOVITCH, VN | 1 |
| PALKINA, NA | 1 |
| BURD, GI | 1 |
| ZAWISZA-ZENKTELER, W | 1 |
| Ambrose, CG | 1 |
| Clyburn, TA | 1 |
| Louden, K | 1 |
| Joseph, J | 1 |
| Wright, J | 1 |
| Gulati, P | 1 |
| Gogola, GR | 1 |
| Mikos, AG | 1 |
| Koort, JK | 1 |
| Mäkinen, TJ | 1 |
| Suokas, E | 1 |
| Veiranto, M | 1 |
| Jalava, J | 1 |
| Knuuti, J | 1 |
| Törmälä, P | 1 |
| Aro, HT | 1 |
| Ludwick, JJ | 1 |
| Rossmann, SN | 1 |
| Johnson, MM | 1 |
| Edmonds, JL | 1 |
| Sayin, B | 1 |
| Caliş, S | 1 |
| Atilla, B | 1 |
| Marangoz, S | 1 |
| Hincal, AA | 1 |
| Störmer, M | 1 |
| Kleesiek, K | 1 |
| Dreier, J | 1 |
| Pollock, HM | 1 |
| Ruf, B | 1 |
| Stewart, KD | 1 |
| Brackett, DJ | 1 |
| Lerner, MR | 1 |
| Archer, LT | 1 |
| Wilson, MF | 1 |
| Martynov, VA | 1 |
| Roslyĭ, IM | 1 |
| Kolobaeva, OV | 1 |
| Calhoun, JH | 1 |
| Mader, JT | 1 |
| Benoit, MA | 1 |
| Mousset, B | 1 |
| Delloye, C | 1 |
| Bouillet, R | 1 |
| Gillard, J | 1 |
| Sasaki, S | 1 |
| Ishii, Y | 1 |
| Kanellakopoulou, K | 1 |
| Galanakis, N | 1 |
| Giamarellos-Bourboulis, EJ | 1 |
| Rifiotis, C | 1 |
| Papakostas, K | 1 |
| Andreopoulos, A | 1 |
| Dounis, E | 1 |
| Karagianakos, P | 1 |
| Giamarellou, H | 1 |
| Boddie, RL | 2 |
| Nickerson, SC | 2 |
| Watts, JL | 1 |
| Ray, CH | 1 |
| Höring, E | 1 |
| Kubin, S | 1 |
| von Gaisberg, U | 1 |
| Musch, TI | 1 |
| Martin, LF | 1 |
| Topley, N | 1 |
| Alobaidi, HM | 1 |
| Davies, M | 1 |
| Coles, GA | 1 |
| Williams, JD | 1 |
| Lloyd, D | 1 |
| Evanchick, CE | 1 |
| Davis, DE | 1 |
| Harrington, TM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Lumbar Interbody Fusion Using The Telamon® Peek™ Versus The Telamon® Hydrosorb™ Fusion Device - A Prospective, Randomized Controlled Trial To Assess Surgical And Clinical Outcomes[NCT00095095] | Phase 4 | 102 participants | Interventional | 2004-10-31 | Terminated | ||
| A National, Prospective, Randomized, Multicenter, Controlled Head-to-Head Comparison of Bioactive Glass and Beta-Tricalcium Phosphate as Bone Graft Substitute in Filling of Contained Bone Defects[NCT00841152] | 120 participants (Actual) | Observational | 2009-03-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for lactic acid and Staphylococcal Infections
| Article | Year |
|---|---|
CSF lactate.
Topics: Adult; Biomarkers; Brain Diseases; Central Nervous System Infections; Enterovirus; Female; Humans; L | 2020 |
Laboratory techniques for detection of urinary tract infection and assessment of value.
Topics: Antibodies; Antibody-Coated Bacteria Test, Urinary; Bacteriological Techniques; Bacteriuria; Culture | 1983 |
58 other studies available for lactic acid and Staphylococcal Infections
| Article | Year |
|---|---|
Minimum inhibitory concentrations of chlorhexidine- and lactic acid-based teat disinfectants: An intervention trial assessing bacterial selection and susceptibility.
Topics: Animals; Cattle; Cattle Diseases; Chlorhexidine; Disinfectants; Female; Lactic Acid; Mammary Glands, | 2022 |
In vitro testing and efficacy of poly-lactic acid coating incorporating antibiotic loaded coralline bioceramic on Ti6Al4V implant against Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Coated Materials, Biocompatible; Gentamicins; Humans; In Vitro Techniques; La | 2022 |
Lactate production by Staphylococcus aureus biofilm inhibits HDAC11 to reprogramme the host immune response during persistent infection.
Topics: Biofilms; Biomarkers; Biosynthetic Pathways; Cytokines; Histone Deacetylases; Host-Pathogen Interact | 2020 |
Surface charge modulation of rifampicin-loaded PLA nanoparticles to improve antibiotic delivery in Staphylococcus aureus biofilms.
Topics: Anti-Bacterial Agents; Biofilms; Drug Delivery Systems; Drug Liberation; Lactic Acid; Microbial Sens | 2021 |
Diagnostic challenge: an atypical presentation of infective endocarditis.
Topics: Bacteremia; Blood Culture; C-Reactive Protein; Diagnosis, Differential; Diarrhea; Dysentery; Early W | 2021 |
Mechanistic insights into cell-free hemoglobin-induced injury during septic shock.
Topics: Acidosis; Acute Lung Injury; Animals; Blood Pressure; Dogs; Heart Ventricles; Hemoglobins; Iron; Lac | 2021 |
Biodegradable rifampicin-releasing coating of surgical meshes for the prevention of bacterial infections.
Topics: Animals; Anti-Bacterial Agents; Coated Materials, Biocompatible; Delayed-Action Preparations; Drug L | 2017 |
Fecal coagulase-negative staphylococci from horses, their species variability, and biofilm formation.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Coagulase; Feces; Gastrointestinal Microbiome; Horses; Lac | 2019 |
Sub-unit vaccine against S. aureus-mediated infections: set-up of nano-sized polymeric adjuvant.
Topics: Adhesins, Bacterial; Adjuvants, Immunologic; Animals; Bacterial Vaccines; Cell Survival; Cells, Cult | 2013 |
Linezolid-induced hyperlactatemia in a burn patient.
Topics: Acetamides; Aged, 80 and over; Anti-Infective Agents; Burns; Female; Humans; Lactic Acid; Linezolid; | 2013 |
A biodegradable antibiotic-impregnated scaffold to prevent osteomyelitis in a contaminated in vivo bone defect model.
Topics: Animals; Anti-Infective Agents; Biodegradable Plastics; Bone Regeneration; Clindamycin; Femur; Genta | 2014 |
Vancomycin containing PLLA/β-TCP controls experimental osteomyelitis in vivo.
Topics: Animals; Bone Development; Bone-Implant Interface; Calcium Phosphates; Lactic Acid; Male; Methicilli | 2014 |
A biodegradable gentamicin-hydroxyapatite-coating for infection prophylaxis in cementless hip prostheses.
Topics: Animals; Anti-Bacterial Agents; Bone Cements; Bone Nails; Coated Materials, Biocompatible; Dogs; Dru | 2015 |
Antibacterial activity and biological performance of a novel antibacterial coating containing a halogenated furanone compound loaded poly(L-lactic acid) nanoparticles on microarc-oxidized titanium.
Topics: Animals; Anti-Bacterial Agents; Cell Proliferation; Coated Materials, Biocompatible; Furans; Lactic | 2015 |
MRSA as a rare cause of vaginitis.
Topics: Administration, Intravaginal; Administration, Oral; Adult; Anti-Bacterial Agents; Female; Humans; La | 2015 |
Glycolytic dependency of high-level nitric oxide resistance and virulence in Staphylococcus aureus.
Topics: Animals; Disease Models, Animal; Drug Tolerance; Female; Fermentation; Glycolysis; Lactic Acid; Mice | 2015 |
Treatment of Staphylococcus aureus-induced chronic osteomyelitis with bone-like hydroxyapatite/poly amino acid loaded with rifapentine microspheres.
Topics: Amino Acids; Animals; Anti-Bacterial Agents; Chronic Disease; Delayed-Action Preparations; Drug Carr | 2015 |
Prevention of Staphylococcus aureus biomaterial-associated infections using a polymer-lipid coating containing the antimicrobial peptide OP-145.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; | 2016 |
Staphylococci Related to Farm Ostriches and Their Sensitivity to Enterocins.
Topics: Animals; Anti-Bacterial Agents; Bridged-Ring Compounds; Farms; Foodborne Diseases; Humans; Lactic Ac | 2016 |
Microencapsulation of rifampicin for the prevention of endophthalmitis: In vitro release studies and antibacterial assessment.
Topics: Anti-Bacterial Agents; Bacterial Adhesion; Chemistry, Pharmaceutical; Delayed-Action Preparations; D | 2016 |
Fighting Off Wound Pathogens in Horses with Honeybee Lactic Acid Bacteria.
Topics: Animals; Bees; Bifidobacterium; Biological Therapy; Honey; Horse Diseases; Horses; Lactic Acid; Lact | 2016 |
CNA-loaded PLGA nanoparticles improve humoral response againstS. aureus-mediated infections in a mouse model: subcutaneous vs. nasal administration strategy.
Topics: Adjuvants, Immunologic; Administration, Intranasal; Animals; Drug Carriers; Female; Immunity, Humora | 2016 |
Reduction of postoperative spinal implant infection using gentamicin microspheres.
Topics: Animals; Anti-Bacterial Agents; Biocompatible Materials; Bone Nails; Delayed-Action Preparations; Dr | 2009 |
Biodegradable microspherical implants containing teicoplanin for the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis.
Topics: Absorbable Implants; Analysis of Variance; Animals; Anti-Bacterial Agents; Disease Models, Animal; D | 2010 |
Subconjunctival delivery of antibiotics in a controlled-release system: a novel anti-infective prophylaxis approach for cataract surgery.
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotic Prophylaxis; Aqueous Humor; Bio | 2010 |
Intra-discal vancomycin-loaded PLGA microsphere injection for MRSA discitis: an experimental study.
Topics: Animals; Anti-Bacterial Agents; Colony Count, Microbial; Discitis; Lactic Acid; Methicillin-Resistan | 2011 |
Effect of zein on biodegradable inserts for the delivery of tetracycline within periodontal pockets.
Topics: Absorbable Implants; Anti-Bacterial Agents; Drug Delivery Systems; Humans; Lactic Acid; Nuclear Magn | 2012 |
Vancomycin containing PLLA/β-TCP controls MRSA in vitro.
Topics: Anti-Bacterial Agents; Biocompatible Materials; Bone Substitutes; Calcium Phosphates; Cell Adhesion; | 2011 |
Bioburden-responsive antimicrobial PLGA ultrafine fibers for wound healing.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Biocompatible Materials; Biofilms; Cellular M | 2012 |
Microfluidic 3D bone tissue model for high-throughput evaluation of wound-healing and infection-preventing biomaterials.
Topics: Animals; Anti-Bacterial Agents; Biocompatible Materials; Bone and Bones; Calcium Phosphates; Cell Li | 2012 |
Modification of TiO(2) nanotube surfaces by electro-spray deposition of amoxicillin combined with PLGA for bactericidal effects at surgical implantation sites.
Topics: 3T3 Cells; Amoxicillin; Animals; Anti-Bacterial Agents; Bone Plates; Cell Adhesion; Cell Proliferati | 2013 |
Protective effect of recombinant staphylococcal enterotoxin A entrapped in polylactic-co-glycolic acid microspheres against Staphylococcus aureus infection.
Topics: Adjuvants, Immunologic; Animals; Bacterial Vaccines; Enterotoxins; Female; Lactic Acid; Mice; Polygl | 2012 |
A lipid-and-polymer-based novel local drug delivery system--BonyPid™: from physicochemical aspects to therapy of bacterially infected bones.
Topics: Animals; Anti-Bacterial Agents; Calcium Phosphates; Chemical Phenomena; Coated Materials, Biocompati | 2012 |
Formulation, antimicrobial and toxicity evaluation of bioceramic based ofloxacin loaded biodegradable microspheres for periodontal infection.
Topics: Animals; Anti-Bacterial Agents; Cell Survival; Chemistry, Pharmaceutical; Escherichia coli; Escheric | 2012 |
Diazeniumdiolate-doped poly(lactic-co-glycolic acid)-based nitric oxide releasing films as antibiofilm coatings.
Topics: Anti-Bacterial Agents; Azo Compounds; Biofilms; Coated Materials, Biocompatible; Escherichia coli; E | 2012 |
Identification of a lactate-quinone oxidoreductase in Staphylococcus aureus that is essential for virulence.
Topics: Animals; Bacterial Proteins; Disease Models, Animal; Genes, Bacterial; Host-Pathogen Interactions; H | 2011 |
Bioabsorbable poly-L-lactic acid cages for lumbar interbody fusion: three-year follow-up radiographic, histologic, and histomorphometric analysis in goats.
Topics: Absorbable Implants; Animals; Bone Remodeling; Drug Implants; Elasticity; Feasibility Studies; Femal | 2002 |
Physiology and antibiotic susceptibility of Staphylococcus aureus small colony variants.
Topics: Acetates; Anti-Bacterial Agents; Culture Media; Drug Resistance, Bacterial; Glucose; Hydrogen-Ion Co | 2002 |
THE ROLE OF LACTATE IN REGULATION OF THE ENZYMATIC SYSTEM SYNTHESIS PARTICIPATING IN THE ACETATE OXIDATION IN STAPHYLOCOCCUS AUREUS.
Topics: Acetates; Citric Acid Cycle; Lactates; Lactic Acid; Metabolism; Oxidation-Reduction; Research; Staph | 1963 |
GLYCOGEN AND LACTIC ACID IN RABBIT'S PERIPHERAL BLOOD IN THE COURSE OF ACUTE STAPHYLOCOCCUS INFECTION.
Topics: Animals; Blood; Communicable Diseases; Glycogen; Lactates; Lactic Acid; Lagomorpha; Rabbits; Researc | 1965 |
Effective treatment of osteomyelitis with biodegradable microspheres in a rabbit model.
Topics: Animals; Anti-Bacterial Agents; Biocompatible Materials; Cefazolin; Disease Models, Animal; Drug Car | 2004 |
Efficacy of ciprofloxacin-releasing bioabsorbable osteoconductive bone defect filler for treatment of experimental osteomyelitis due to Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Bone Cements; Ciprofloxacin; Coated Materials, Biocompatible; Diseas | 2005 |
The bacteriostatic properties of ear tubes made of absorbable polylactic acid.
Topics: Absorbable Implants; Anti-Infective Agents; Child; Humans; Lactic Acid; Middle Ear Ventilation; Otit | 2006 |
Implantation of vancomycin microspheres in blend with human/rabbit bone grafts to infected bone defects.
Topics: Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Biocompatible Materials; Bone Transplantatio | 2006 |
pH value promotes growth of Staphylococcus epidermidis in platelet concentrates.
Topics: Bacteremia; Blood Donors; Blood Platelets; Blood Preservation; Citrates; Cryopreservation; Humans; H | 2008 |
[Lactate determination in the cerebrospinal fluid. Differential diagnostic significance].
Topics: Diagnosis, Differential; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Lactate | 1981 |
Comparison of Staphylococcus aureus and Escherichia coli infusion in conscious rats.
Topics: Animals; Bacteremia; Blood Glucose; Carbon Dioxide; Cardiac Output; Escherichia coli; Escherichia co | 1994 |
[The enzyme activity and pyruvate, lactate and 2,3-DPG levels in the erythrocytes of patients with severe forms of meningococcal infection and suppurative meningitis].
Topics: 2,3-Diphosphoglycerate; Adolescent; Adult; Aged; Diphosphoglyceric Acids; Erythrocytes; Female; Huma | 1996 |
Treatment of osteomyelitis with a biodegradable antibiotic implant.
Topics: Animals; Anti-Bacterial Agents; Biodegradation, Environmental; Disease Models, Animal; Drug Delivery | 1997 |
Antibiotic-loaded plaster of Paris implants coated with poly lactide-co-glycolide as a controlled release delivery system for the treatment of bone infections.
Topics: Animals; Anti-Bacterial Agents; Biocompatible Materials; Biodegradation, Environmental; Calcium Sulf | 1997 |
Apatite cement containing antibiotics: efficacy in treating experimental osteomyelitis.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Apatites; Bone Cements; Bone Marrow; Bone T | 1999 |
Treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with a biodegradable system of lactic acid polymer releasing pefloxacin.
Topics: Animals; Anti-Infective Agents; Colony Count, Microbial; Drug Implants; Excipients; Lactic Acid; Mal | 2000 |
Evaluation of postmilking teat germicides containing Lauricidin, saturated fatty acids, and lactic acid.
Topics: Animals; Cattle; Disinfectants; Fatty Acids; Female; Glycerides; Lactates; Lactic Acid; Laurates; Ma | 1992 |
Effect of postmilking teat antisepsis on teat canal infections in lactating dairy cows.
Topics: Animals; Antisepsis; Cattle; Fatty Acids; Female; Iodophors; Lactates; Lactation; Lactic Acid; Masti | 1990 |
[Spontaneous bacterial peritonitis: studies of the incidence and clinical and laboratory chemical parameters].
Topics: Ascitic Fluid; Bacterial Infections; Bacteriological Techniques; Blood Glucose; Blood Proteins; Chol | 1990 |
The effects of chronic bacteremia on the metabolic response to exercise in the conscious rat.
Topics: Acid-Base Equilibrium; Animals; Bacteroides fragilis; Bacteroides Infections; Blood Gas Analysis; Bl | 1988 |
The effect of dialysate on peritoneal phagocyte oxidative metabolism.
Topics: Dialysis Solutions; Humans; Hydrogen-Ion Concentration; Lactates; Lactic Acid; Luminescent Measureme | 1988 |
Septic arthritis. Clinical approach to the 'hot joint'.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Arthritis, Infectious; Arthritis, Rheumatoid; Child; Diagn | 1986 |